Les personnes
Nos collaborateurs sont notre atout le plus précieux et leur qualité, leur créativité et leur dévouement sont indispensables à notre réussite.
Recherche de personnes
Dernières nouvelles Nos collaborateurs
January 23, 2026
Deals and Wins
Foley Represents TCGX as Investor in $287M Series D1 Financing for CORXEL
Foley & Lardner LLP represented TCGX Crossover (TCGX) as an investor in the $287 million Series D1 financing for CORXEL, a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for patients with cardiometabolic conditions around the world.
January 23, 2026
Deals and Wins
Foley Represents DLB in Sale of Majority Stake to Accenture
Foley & Lardner LLP represented DLB Associates and its affiliated companies (collectively “DLB”), an industry leader and trailblazer in engineering and consulting services for data centers and related mission critical facilities, in the sale of a majority stake to Accenture (NYSE: ACN).
January 23, 2026
In the News
Judith Waltz Comments on DOJ Medicaid Fraud Crackdown
Foley & Lardner LLP Judith Waltz was quoted in the Report on Medicare Compliance article, “Trump Creates DOJ Fraud Enforcement Division, Targets Minn. Medicaid Payments,” on the Department of Justice (DOJ) Division for National Fraud Enforcement and its targeted actions against Medicaid fraud in Minnesota.